Andrew J Brown. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AnimalsAnticholesteremic Agents/pharmacologyAnticholesteremic Agents/therapeutic useArteriosclerosis/metabolismArteriosclerosis/prevention & controlAzetidines/pharmacologyAzetidines/therapeutic useCholesterol/metabolismEzetimibeHumansHydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacologyHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic useHypercholesterolemia/drug therapyHypercholesterolemia/metabolismIntestinal Absorption/drug effectsLipoproteins/metabolism
Substances: See more » Anticholesteremic AgentsAzetidinesHydroxymethylglutaryl-CoA Reductase InhibitorsLipoproteinsCholesterolEzetimibe
Year: 2002 PMID: 12441896 DOI: 10.1097/00041433-200212000-00016
Source DB: PubMed Journal: Curr Opin Lipidol ISSN: 0957-9672 Impact factor: 4.776